Investigation of Biomarkers for Sugars Intake - A Controlled Feeding Study

糖摄入量生物标志物的研究 - 一项控制喂养研究

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Apart from sugars' proven association with dental caries and obesity, the link to cardiovascular disease, type 2 diabetes and cancer remains largely inconclusive. Most population studies rely on self-reported measures of diet, known to be associated with large measurement error, which may be obscuring the true relationship between sugars and disease risk and may explain the lack of consistency in the observed evidence. Development of novel approaches for obtaining more accurate estimates of intake is crucial for attaining more reliable risk estimates for sugars and disease risk. Recently, 24-h urinary sucrose and fructose (24uSF) was developed as a biomarker of sugars intake in two UK-based feeding studies. However, evidence on the performance and the validity of this biomarker in U.S. participants and in the context of a U.S. diet is lacking. Further, the utility of uSF measure in spot urines has never been investigated and could have significant implications for epidemiologic studies. Another promising sugars biomarker, the carbon stable isotope ratio (d13C) in red blood cell (RBCs) has been recently developed among Alaska Natives. This biomarker has been tested against self-reports only, and has never been investigated in a feeding study with known intake. We now propose a 15-d highly-controlled feeding study to comprehensively investigate the performance of 24uSF and d13C as biomarkers of sugars intake, individually and in combination, and to inform future application of these promising biomarkers among U.S. participants. The study will involve 107 men and women aged 18-70 y, consuming only foods and beverages provided by the study metabolic kitchen for 15-d, that will mimic their usual diet, assessed previously by two 7-d food records. Over the 15-d feeding period, participants will collect 8 nonconsecutive 24-h urines, and blood samples will be collected at baseline, at study completion, and 5 weeks post-study completion. First we will investigate the performance of 24uSF as a biomarker of sugars intake and we will develop a calibration equation that will define the future application of 24uSF as an unbiased measure of sugars in U.S. participants. Further, we will investigate the utility of measuring uSF in spot urin as a biomarker of intake; on two 24-h urine collection days, participants will collect urine voids n separate containers. Second, we will investigate the performance of RBCs d13C as a biomarker of sugars intake among U.S. participants under controlled conditions of a feeding study. We will also explore the use of 24-h urinary d13C as a measure of sugars intake. Third, we will investigate approaches of combining 24uSF and d13C in a unique measure. Combining these two unrelated biomarkers with different sources of error and with different time-relation to intake may provide a superior measure of intake. This study will develop validated sugars biomarkers that can be used as unbiased measures of sugars intake among U.S. individuals that will ultimately allow obtaining reliable risk estimates of sugars-disease associations. Until strong and consistent evidence for adverse health effects of sugars is found, no firm guidance can be given to the general public.
 描述(由申请人提供):除了糖已被证实与龋齿和肥胖相关外,糖与心血管疾病、2 型糖尿病和癌症的联系在很大程度上仍然没有定论。大多数人口研究依赖于自我报告的饮食测量,已知这些测量误差与较大的测量误差有关,这可能会掩盖糖与疾病风险之间的真实关系,并可能解释观察到的证据缺乏一致性。开发新方法来获得更准确的摄入量估计对于获得更可靠的糖和疾病风险估计至关重要。最近,两项基于英国的喂养研究开发了 24 小时尿蔗糖和果糖 (24uSF) 作为糖摄入量的生物标志物。然而,缺乏关于该生物标志物在美国参与者和美国饮食背景下的表现和有效性的证据。此外,uSF 测量在点尿中的效用从未被研究过,并且可能对流行病学研究产生重大影响。另一种有前途的糖类生物标志物,红细胞 (RBC) 中的碳稳定同位素比率 (d13C) 最近在阿拉斯加原住民中开发出来。该生物标志物仅根据自我报告进行了测试,并且从未在已知摄入量的喂养研究中进行过研究。我们现在提出一项为期 15 天的高度控制喂养研究,以全面研究 24uSF 和 d13C 作为糖摄入生物标志物(单独或组合)的性能,并为这些有前途的生物标志物在美国参与者中的未来应用提供信息。该研究将涉及 107 名年龄在 18 岁至 70 岁之间的男性和女性,在 15 天内仅食用研究代谢厨房提供的食物和饮料,这将模仿他们之前通过两个 7 天食物记录评估的平时饮食。在 15 天的喂养期间,参与者将收集 8 次非连续 24 小时尿液,并在基线、研究完成时和研究完成后 5 周收集血液样本。首先,我们将研究 24uSF 作为糖摄入量生物标志物的性能,并且我们将开发一个校准方程,该方程将定义 24uSF 作为美国参与者糖分的无偏测量的未来应用。此外,我们将研究测量尿点中 uSF 作为摄入生物标志物的效用;在两个 24 小时尿液收集日,参与者将在不同的容器中收集尿液。其次,我们将在一项喂养研究的受控条件下调查美国参与者中红细胞 d13C 作为糖摄入生物标志物的表现。我们还将探索使用 24 小时尿 d13C 作为糖摄入量的衡量标准。第三,我们将研究以独特的方式结合 24uSF 和 d13C 的方法。将这两个不相关的生物标志物与不同的误差源和与摄入量的时间关系不同的组合起来 可以提供更好的摄入量测量。这项研究将开发经过验证的糖生物标志物,可用作美国个人糖摄入量的公正衡量标准,最终将获得糖与疾病关联的可靠风险估计。直到坚强和 虽然已经找到了糖对健康不利影响的一致证据,但无法向公众提供明确的指导。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Urinary Sucrose and Fructose From Spot Urine May Be Used as a Predictive Biomarker of Total Sugar Intake-Findings From a Controlled Feeding Study.
现场尿中的尿蔗糖和果糖可用作总糖摄入量的预测生物标志物——来自控制喂养研究的发现。
  • DOI:
    10.1016/j.tjnut.2023.04.002
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tasevska,Natasha;Palma-Duran,SusanaA;Sagi-Kiss,Virag;Commins,John;Barrett,Brian;Kipnis,Victor;Midthune,Douglas;O'Brien,DianeM;Freedman,LaurenceS
  • 通讯作者:
    Freedman,LaurenceS
Investigating the performance of 24-h urinary sucrose and fructose as a biomarker of total sugars intake in US participants - a controlled feeding study.
研究美国参与者 24 小时尿蔗糖和果糖作为总糖摄入量生物标志物的表现 - 一项对照喂养研究。
  • DOI:
    10.1093/ajcn/nqab158
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tasevska,Natasha;Sagi-Kiss,Virag;Palma-Duran,SusanaA;Barrett,Brian;Chaloux,Matthew;Commins,John;O'Brien,DianeM;Johnston,CarolS;Midthune,Douglas;Kipnis,Victor;Freedman,LaurenceS
  • 通讯作者:
    Freedman,LaurenceS
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Natasha Tasevska其他文献

Natasha Tasevska的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Natasha Tasevska', 18)}}的其他基金

Application of predictive biomarkers of sugars and animal protein intake for investigation of dietary measurement error and its effect on diet-disease associations
应用糖和动物蛋白摄入量的预测生物标志物研究饮食测量误差及其对饮食与疾病关联的影响
  • 批准号:
    10522649
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
Application of predictive biomarkers of sugars and animal protein intake for investigation of dietary measurement error and its effect on diet-disease associations
应用糖和动物蛋白摄入量的预测生物标志物研究饮食测量误差及其对饮食与疾病关联的影响
  • 批准号:
    10881492
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
Application of predictive biomarkers of sugars and animal protein intake for investigation of dietary measurement error and its effect on diet-disease associations
应用糖和动物蛋白摄入量的预测生物标志物研究饮食测量误差及其对饮食与疾病关联的影响
  • 批准号:
    10705720
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
Investigation of Biomarkers for Sugars Intake - A Controlled Feeding Study
糖摄入量生物标志物的研究 - 一项控制喂养研究
  • 批准号:
    9100691
  • 财政年份:
    2015
  • 资助金额:
    $ 10万
  • 项目类别:
Investigation of Biomarkers for Sugars Intake - A Controlled Feeding Study
糖摄入量生物标志物的研究 - 一项控制喂养研究
  • 批准号:
    8945307
  • 财政年份:
    2015
  • 资助金额:
    $ 10万
  • 项目类别:

相似海外基金

Biosynthesis of bet-alanine in autolysosomes.
自溶酶体中 β-丙氨酸的生物合成。
  • 批准号:
    22K08681
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding the metabolic consequences of the systemic alanine depletion in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中全身丙氨酸消耗的代谢后果
  • 批准号:
    474506
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
    Studentship Programs
Characterizing alanine transporters as therapeutic targets for pancreatic cancer
将丙氨酸转运蛋白描述为胰腺癌的治疗靶点
  • 批准号:
    466496
  • 财政年份:
    2021
  • 资助金额:
    $ 10万
  • 项目类别:
    Studentship Programs
Understanding the requirements of alanine supply and demand in pancreatic ductal adenocarcinoma
了解胰腺导管腺癌中丙氨酸的供需要求
  • 批准号:
    451838
  • 财政年份:
    2021
  • 资助金额:
    $ 10万
  • 项目类别:
    Operating Grants
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10230924
  • 财政年份:
    2021
  • 资助金额:
    $ 10万
  • 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10399593
  • 财政年份:
    2021
  • 资助金额:
    $ 10万
  • 项目类别:
Sensing living P. aeruginosa using D-alanine derived radiotracers
使用 D-丙氨酸衍生的放射性示踪剂感测活的铜绿假单胞菌
  • 批准号:
    10570987
  • 财政年份:
    2021
  • 资助金额:
    $ 10万
  • 项目类别:
Spot measurement of alanine radicals produced by irradiation and application of sugar radial to dosimeter
辐照产生的丙氨酸自由基的点测及糖自由基在剂量计中的应用
  • 批准号:
    19K05343
  • 财政年份:
    2019
  • 资助金额:
    $ 10万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Metabolic significance of lysosomal beta-alanine
溶酶体β-丙氨酸的代谢意义
  • 批准号:
    18K08528
  • 财政年份:
    2018
  • 资助金额:
    $ 10万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of dosimetry technique for IMRT using alanine dosimeter
使用丙氨酸剂量计开发 IMRT 剂量测定技术
  • 批准号:
    18K15615
  • 财政年份:
    2018
  • 资助金额:
    $ 10万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了